👀 Semis Crash, CPI Cools to 3.5%, and CRDF's CEO Bets $50K on Her Own Raise

Good afternoon and happy Sunday! Here is a quick market rundown and an 'inside' peek behind the curtains of what C-Level Execs, Wall St. Hedge Fund Gurus, and politicians are trading right now…!

📊 Market Performance

• Dow Jones Industrial Average: 52,146.42 (-0.77% Friday, -0.9% on the week)

• S&P 500: 7,457.69 (-1.01% Friday, -1.6% on the week)

• Nasdaq Composite: 25,520.24 (-1.40% Friday, -2.9% on the week)

The S&P is still up roughly 9% year-to-date, so zoom out before you panic — but this was the index's worst week in months, and it was entirely a concentration story. The S&P 500 Equal Weight Index materially outperformed the cap-weighted S&P this week, which tells you the damage was concentrated in mega-cap tech and semis, not spread across the broader market. Consumer staples names actually finished the week higher. The Philadelphia Semiconductor Index (SOX) is down more than 13% in the past month and touched official bear-market territory Friday — but it's worth remembering it's still up roughly 63% year-to-date. This is a drawdown inside a still-massive uptrend, not (yet) a trend change.

🔑 Key Drivers

🧨 The AI Trade Hit a Wall Chinese AI startup Moonshot released a new open model this week that traders read as a real competitive threat to U.S. AI leaders, and it landed on a market that was already nervous about how much has been spent — and priced in — on the AI buildout. That single headline did more damage to sentiment than anything macro this week.

💾 Semiconductors Officially Entered a Bear Market The SOX index's slide deepened Friday as the sector fell more than 20% from its recent record, with the VanEck Semiconductor ETF (SMH) posting its third weekly decline in four weeks, down almost 9% on the week alone. Micron was a rare bright spot, up over 7% on a $3 billion U.S. manufacturing investment announcement — a reminder that this is a repricing of the group, not a uniform collapse.

🏦 CPI Cooled to 3.5% — But the Fed Isn't Celebrating June CPI fell 0.4% month-over-month, the largest single-month drop since April 2020, bringing the annual rate down to 3.5% from May's 4.2% and well below the 3.8% consensus. Core CPI held flat on the month at 2.6% year-over-year. The catch: most of the improvement came from a 10% drop in June gasoline prices tied to the temporary Hormuz reopening — and Fed Chair Kevin Warsh was blunt about it, saying "there might be some that look at this morning's data and say, 'Oh, mission accomplished, everything is swell' — that is not my view." Markets are still leaning toward the Fed holding rates, not cutting, at the July 28–29 meeting.

⚔️ Iran Tensions Re-Escalated Just as the gasoline-driven CPI relief was landing, renewed U.S.-Iran tensions pushed back the other way, with reports the administration is weighing a fresh blockade posture. Oil prices, which had been sliding on ceasefire hopes, are back in play as the key swing factor for the next CPI print — the June relief may prove temporary if the July data captures this week's tension instead.

🏦 Bank Earnings Opened Q2 Season JPMorgan, Goldman Sachs, Wells Fargo, and Citigroup reported Tuesday, with Morgan Stanley following Wednesday. Trading and investment-banking revenue were the standout lines across the group — the real tell going forward is net-interest-margin guidance, not the headline EPS beats, as the market tries to gauge how a "higher for longer" Fed actually flows through to bank profitability.

🔬 CRDF: When the CEO Pays More Than the Institutions Cardiff Oncology (CRDF) priced a $10.05 million registered direct offering this week — and instead of just watching from the sidelines, CEO Mani Mohindru and a group of company officers and directors bought in alongside the institutional investors. The twist: institutional buyers paid $1.05 per share, but insiders paid $1.455 — a real premium, not a sweetheart deal. That's the opposite of the optics you'd expect from a dilutive raise, and it's exactly the kind of insider signal this newsletter exists to flag. Full breakdown below.

KEY TAKEAWAYS:

✅ Key Takeaways

• 📉 The SOX is in a bear market — down over 20% from its high, but still up ~63% YTD. Context matters before you extrapolate.

• 🌡️ CPI cooled to 3.5%, but the Fed's own chair is telling you not to celebrate yet — gasoline math, not demand destruction, drove the headline.

• ⚔️ Iran risk is back on the board — watch oil, not just the index level, for the next real signal.

• 🏦 Big bank earnings season opened strong on trading revenue — NIM guidance is the number that actually matters from here.

• 🧮 Equal-weight crushed cap-weight this week — a sign this was a mega-cap/AI-trade problem, not a broad-market one.

• 🔬 CRDF's CEO paid a premium to buy into her own company's raise — that's not a signal management fakes.

🔎 What We're Watching Next Week

📱 Big Tech Earnings Wednesday — Tesla, Alphabet, Intel, Texas Instruments All four report Wednesday, July 22, and together they're the real referendum on whether this week's AI-trade selloff was an overreaction or the start of a genuine re-rating. Intel and Texas Instruments in particular will tell us whether the chip-demand story is actually cracking or whether this was purely a sentiment shock.

🌎 Flash PMIs, Late Week Global flash manufacturing, services, and composite PMI readings land toward the end of the week and will be the first real look at July economic activity — a useful cross-check against how much the AI-trade wobble has bled into the broader economy.

⚔️ Iran / Oil Watch With tensions re-escalating just as gasoline prices had been providing CPI relief, any further developments here matter for both markets and the next inflation print. Watch crude, not headlines, for the real signal.

🏦 More Earnings: HCA, American Express, Verizon, Charter, NextEra A broader read-through week for healthcare, consumer credit, telecom, and utilities — useful context for whether this week's damage was purely a tech/semis story or starting to show up elsewhere.

🔬 Insider Spotlight: Cardiff Oncology (CRDF) On July 14, CEO Mani Mohindru purchased 34,364 shares of Cardiff Oncology common stock in the open market at $1.455 per share — roughly $50,000 out of pocket — along with 34,364 common stock purchase warrants exercisable at $1.33. She wasn't alone: Mohindru and a group of fellow officers and directors collectively committed to purchasing approximately 721,649 shares (plus matching warrants) as part of the company's broader $10.05 million registered direct offering that closed this week.

What makes this worth flagging isn't just that insiders bought — it's the price they paid to do it. Institutional investors in the same offering paid $1.05 per share; insiders paid $1.455, a roughly 39% premium. Insiders had no obligation to participate on worse terms than outside investors, and did anyway. Over the trailing twelve months, CRDF has now seen three separate insider buys and zero insider sells — a clean, one-directional signal from the people who know the company best, in a stock most of the market has otherwise ignored at a sub-$100 million market cap.

That's the week. See you next Sunday.

— Silas P. Insider Authority | insiderauthority.com

Insider spotlight of the week…#CRDF

^{Here is a snapshot of last week’s recent insider activity…}

C-Level Execs

Hedge Funds

👉 Want direct access to all insider moves — including U.S. stocks, politicians, hedge funds — in real time? Our Elite Insider Dashboard surfaces high-signal trades as they hit the tape. Stay ahead of the herd.

🔗 [Join Elite Insider today]

Want to learn how to leverage INSIDER TRADING ACTIVITY to potentially beat the market?

Look no further than ELITE INSIDER (EI) — a complete ‘all in one’ software dashboard and scanner that tracks the political, corporate, and hedge fund insider trading activity.

EI includes cluster buying, largest trade and most active trade scanners, interactive charting + data suite and our Insider Portfolio Alerts (IPA). It’s time to bridge the gap from main street to Wall Street by following smart money insiders.

See you on the ‘INSIDE.’

P.S. Interested in joining hundreds of traders using our 0DTE mechanical systems to generate consistent, long-term income all without wasting hours analyzing setups? Check out Option Income Project here.